Advertisement
AZR vs VANI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZR is a Buy and VANI is a Buy.
AZR's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for AZR turned positive on October 20, 2026. Looking at past instances where AZR's MACD turned positive, the stock continued to rise in 40 of 44 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AZR's RSI Indicator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on AZR as a result. In 86 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
Following a +37.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where AZR advanced for three days, in 157 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
AZR moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AZR crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AZR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
AZR broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AZR entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AZR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.386) is normal, around the industry mean (3.162). P/E Ratio (-0.285) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AZR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
VANI in -3.45% downward trend, falling for three consecutive days on October 16, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where VANI declined for three days, in 249 of 293 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VANI as a result. In 71 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The 50-day moving average for VANI moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VANI's RSI Oscillator exited the oversold zone, 19 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 65 cases where VANI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for VANI just turned positive on October 28, 2026. Looking at past instances where VANI's MACD turned positive, the stock continued to rise in 37 of 50 cases over the following month. The odds of a continued upward trend are 74%.
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where VANI advanced for three days, in 158 of 209 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
VANI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.184) is normal, around the industry mean (3.162). P/E Ratio (-3.028) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. VANI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VANI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
AZR | VANI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 11 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 35 Fair valued | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 34 | 75 | |
P/E GROWTH RATING 1..100 | 96 | 23 | |
SEASONALITY SCORE 1..100 | 50 | 37 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AZR's Valuation (35) in the Pharmaceuticals Major industry is somewhat better than the same rating for VANI (69) in the null industry. This means that AZR’s stock grew somewhat faster than VANI’s over the last 12 months.
AZR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that AZR’s stock grew similarly to VANI’s over the last 12 months.
AZR's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that AZR’s stock grew similarly to VANI’s over the last 12 months.
AZR's Price Growth Rating (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for VANI (75) in the null industry. This means that AZR’s stock grew somewhat faster than VANI’s over the last 12 months.
VANI's P/E Growth Rating (23) in the null industry is significantly better than the same rating for AZR (96) in the Pharmaceuticals Major industry. This means that VANI’s stock grew significantly faster than AZR’s over the last 12 months.
| AZR | VANI | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 88% | 4 days ago 68% |
| Stochastic ODDS (%) | 4 days ago 90% | 4 days ago 75% |
| Momentum ODDS (%) | 4 days ago 85% | 4 days ago 78% |
| MACD ODDS (%) | 4 days ago 90% | 4 days ago 74% |
| TrendWeek ODDS (%) | 4 days ago 90% | 4 days ago 80% |
| TrendMonth ODDS (%) | 4 days ago 90% | 4 days ago 81% |
| Advances ODDS (%) | 6 days ago 76% | 7 days ago 76% |
| Declines ODDS (%) | 4 days ago 90% | 18 days ago 85% |
| BollingerBands ODDS (%) | 4 days ago 90% | 4 days ago 89% |
| Aroon ODDS (%) | 4 days ago 90% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AZR’s FA Score shows that 0 FA rating(s) are green while VANI’s FA Score has 1 green FA rating(s).
- AZR’s FA Score: 0 green, 5 red.
- VANI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AZR’s TA Score shows that 4 TA indicator(s) are bullish while VANI’s TA Score has 5 bullish TA indicator(s).
- AZR’s TA Score: 4 bullish, 6 bearish.
- VANI’s TA Score: 5 bullish, 3 bearish.
Price Growth
AZR (@Biotechnology) experienced а -2.81% price change this week, while VANI (@Biotechnology) price change was -1.80% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.20%. For the same industry, the average monthly price growth was -14.01%, and the average quarterly price growth was -15.33%.
Reported Earning Dates
AZR is expected to report earnings on Nov 12, 2026.
VANI is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (+0.20% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
AZR and
Correlation & Price change
A.I.dvisor indicates that over the last year, AZR has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AZR jumps, then SYRE could also see price increases.
| Ticker / NAME | Correlation To AZR | 1D Price Change % | ||
|---|---|---|---|---|
| AZR | 100% | -20.79% | ||
| SYRE - AZR | 39% Loosely correlated | -2.43% | ||
| VANI - AZR | 37% Loosely correlated | -4.39% | ||
| VTVT - AZR | 29% Poorly correlated | -4.59% | ||
| GMAB - AZR | 28% Poorly correlated | +1.01% | ||
| GDTC - AZR | 27% Poorly correlated | -0.66% | ||
More | ||||
VANI and
Correlation & Price change
A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.
| Ticker / NAME | Correlation To VANI | 1D Price Change % | ||
|---|---|---|---|---|
| VANI | 100% | -4.39% | ||
| VTVT - VANI | 60% Loosely correlated | -4.59% | ||
| AZR - VANI | 37% Loosely correlated | -20.79% | ||
| AXSM - VANI | 36% Loosely correlated | +0.68% | ||
| NKTX - VANI | 34% Loosely correlated | -6.02% | ||
| SCNI - VANI | 34% Loosely correlated | -9.05% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NUV | 8.44 | 0.08 | +0.96% |
| Nuveen Municipal Value Fund | |||
| KBAB | 6.45 | N/A | N/A |
| KraneShares 2x Long BABA Daily ETF (KBAB) | |||
| DDTY | 20.85 | N/A | N/A |
| Innovator Equity Dual Directional 10 Buffer ETF - MAY (DDTY) | |||
| FPA | 43.93 | -0.49 | -1.11% |
| First Trust Asia Pacific ex-Japan AlphaDEX Fund (FPA) | |||
| METU | 21.54 | -0.72 | -3.23% |
| Direxion Daily META Bull 2X ETF (METU) | |||